This metabolite features a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 somewhere around fifty% from the mum or dad drug. Plasma concentrations of this metabolite are around 40% of those seen for sildenafil, so which the metabolite accounts for around 20% of sildenafil's pharmacologic consequences.Additional inform